Panbela Therapeutics Inc (PBLA)
0.48
+0.08
(+20.00%)
USD |
OTCM |
May 16, 16:00
Panbela Therapeutics Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.40M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.001M |
| June 30, 2022 | -0.655M |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.50M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | -0.501M |
| September 30, 2014 | -0.0356M |
| June 30, 2014 | 0.0374M |
| March 31, 2014 | -0.0018M |
| December 31, 2013 | -0.1418M |
| September 30, 2013 | 0.0598M |
| June 30, 2013 | 0.0427M |
| March 31, 2013 | 0.0342M |
| December 31, 2012 | 0.0028M |
| September 30, 2012 | -0.0026M |
| June 30, 2012 | -0.0002M |
| March 31, 2012 | 0.0191M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.655M
Minimum
Jun 2022
0.40M
Maximum
Sep 2023
-0.0284M
Average
--
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.08M |
| Cash from Financing (Quarterly) | 4.749M |
| Free Cash Flow | -25.25M |
| Free Cash Flow Per Share (Quarterly) | -6.416 |
| Free Cash Flow Yield | -31.15K% |